Adamas Pharmaceuticals Inc

Ticker ADMS

Exchange NASDAQ More
Industry Drugs - Generic More
Sector Healthcare More

51-200 Employees
Based in Emeryville, California

Adamas Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapeutics targeting chronic disorders of the central nervous systems in the United States. The company’s lead product candidate ADS-5102, which completed the Phase II/III clinical trial for the treatment of Parkinson's disease, known as levodopa induced dyskinesia.

Visit website

REPORT RATINGS

4.7 / 5.0 (254)

Adamas Pharmaceuticals Inc reports have an aggregate usefulness score of 4.7 based on 254 reviews.

Adamas Pharmaceuticals Inc

Most Recent Annual Report

MOST RECENT 2020 Annual Report and Form 10K

Report Locked. Adamas Pharmaceuticals Inc has reached its limit for free report views.

Adamas Pharmaceuticals Inc does not currently have any hardcopy reports on AnnualReports.com. Click the button below to request a report when hardcopies become available.

Please fill out the form below and click "Place Order" to complete your order.